After the Food and Drug Administration warned consumers that the Type 2 diabetes medication, Actos, has been linked to an increased risk of bladder cancer, the drug’s maker, Takeda Pharmaceuticals, announced that they will be conducting a 10-year study into this link.
The study will involve the observation of diabetes patients. The 193, 099 participants selected for the study are 40-years old or older. Researchers will be looking at whether or not any of the patients receive a new diagnosis of bladder cancer after taking Actos to treat their diabetes.
Data from the drug manufacturer reveals that the risk of bladder cancer increases with an increased dosage of Actos and increased length of time spent taking Actos. Signs of bladder cancer include the presence of blood in the urine, frequent urination, and pain during urination.
If you or someone you love has developed bladder cancer after taking Actos, contact the Actos lawsuit attorneys of Williams Kherkher at 800-641-9810 to learn more about how we can help you.